Xiaobing Y. Huang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.
Journal: Blood cancer discovery
Published: April 10, 2026
Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia.
Journal: European journal of haematology
Published: April 08, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
AML-Targeted Metal-Polyphenol Nanoplatform Induces Ferroptosis-ICD Cascade for Antitumor Immunity Boosting.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 15, 2025
CD19-negative relapse after CAR-T cell therapy: mechanisms of antigen escape and lineage switch.
Journal: Frontiers in immunology
Published: August 25, 2025
CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
A case of primary biliary cholangitis combined with autoimmune pancreatitis and autoimmune gastritis
A case of primary biliary cholangitis combined with autoimmune pancreatitis and autoimmune gastritis
Journal: Zhonghua nei ke za zhi
Published: March 06, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease.
Journal: Cancer pathogenesis and therapy
Published: September 02, 2024
Last Updated: 09/26/2026